Last updated on July 2019

Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS)


Brief description of study

The main purpose of the study is to assess the health-related quality of life (HRQoL) through the Multiple Sclerosis Quality of Life-54 Questionnaire (MSQoL-54) scale in highly-active relapsing multiple sclerosis (RMS) subjects treated with Mavenclad for 2 years (24 months).

Clinical Study Identifier: NCT03369665

Find a site near you

Start Over

Eva Maida

Wien, Austria
  Connect »

H pital Erasme

Brussels, Belgium
  Connect »

UZ Antwerpen

Edegem, Belgium
  Connect »

Matthias Kant

Sønderborg, Denmark
  Connect »

Hopital Pellegrin

Bordeaux Cedex, France
  Connect »

H pital G n ral

Dijon Cedex, France
  Connect »

CHU de Nantes

Nantes Cedex 01, France
  Connect »

CHU de Poissy

Poissy Cedex, France
  Connect »

VALEOMED Kft

Esztergom, Hungary
  Connect »

Catharina Ziekenhuis

Eindhoven, Netherlands
  Connect »

GHZ

Gouda, Netherlands
  Connect »

Zuyderland

Sittard-Geleen, Netherlands
  Connect »

VieCuri Hospital

Venlo, Netherlands
  Connect »

Matthias Kant

Sønderborg, Denmark
  Connect »

Matthias Kant

Sønderborg, Denmark
  Connect »

Matthias Kant

Sønderborg, Denmark
  Connect »

Matthias Kant

Sønderborg, Denmark
  Connect »

Matthias Kant

Sønderborg, Denmark
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.